INTRODUCTION
Being prostate hyperplasia (BPH) is one of the most common problems causing many urinary symptomatology according to aging process. Hitherto numerous etiopathological theories have been but forward to explain its occurance e.g. Metabolic, nutritional neoplastic, inflammatory hormonal etc. However it is clear that there are two major factors responsible for the precipitation of BPH i.e the presence of testes and aging.
In Ayurvadic literature many types of Mutra Rogas are described among of them vatastheela and mutrgranthi are very nearer to the BPH according to symptomatology.
The management of this disease is totally based on the tridoshic principle.
The activities in the lower one third part of the body are governed by the function of the vata, where downwards mobility function like passeages of urine flatus faces, shukra garbha etc are concerned with apan vayu. Besides on this Ayurvadic principles most of the urological disorders (Mutra Rogas) are due to vitiation of Apan Vayu. According to charka when vayu is vitiated severely there is no ramedy other than vasti for pacification. Under that circumstances vastichikitsa is considered as the treatment of choice for such vitiated vatic diseases for normalization vasti suppress the elevated vata, pitta, Kapha "Rakta and also combination of two and three doshas, predominately vasti used in vatic disorders. 
MATERIALS & METHODS

Patients
Categorisation of patients
This study was carried out in Hundred patients of benign prostate Hyperplasia. These patients were cotegorised in two groups:- 
METHOD OF TREATMENT
1) PREPARATION OF PATIENTS
Before administration of main procedure, for kostha sudhi satshakara churna was given 3-5 gram with luckewarm water at Bed time for three days. 4. Varun a Kwatha -50 ml BD 5. Sudha Kupeelu Churna -60 -125 mg BD with honey followed by a glass of milk.
2) MAIN PROCEDURE
ASSESSMENT
After 21 days the indwelling catheter was remove of Group A patients were assessed clinical as well as by physical examination, Patients of both group A&B were also examined by laboratory investigations and finding of pretherapy and post therapy were compared.
RESULTS
In the study the results are in this study the results are encouraging particularly reduction in weight of prostate, decrease in residual urine and also decrease in free serum testosterone.
Hundred patients of BPH were included in this study out of 100 cases in and according to grade. In this study all the patients were subjected to vastikarma and observation of pretreatment and post treatment were evaluated.
Ultrasonographic study of relieved and not relieved patients after treatment revealed that maximum 35 patients 76.09% were relieved and minimum 23.91% (11 patients ) were not relived in Grade II. In grade I 26 patients (72.22%) were relieved and 10 patients were not relieved. In grade III 10 patients (66.66%) were relieved and 5 patients (33.33%) were not relieved. In Grade IV out of three, all patients were not relived. On grand total 71 patients were relieved where as 29 patients were not relieved. (Table No After the completion of therapy the USG study shows that those patients who got relief after treatment there was reduction in weight of prostate.
The reduction of weight was uniform. In some cases there were no change in weigh and in come cases there were no change in weight and in some increases the weight if prostate.
When the reduction of weight of prostate was more than 10 grams it is significant reduction and when the weight of prostate was reduced less than 10 grams that is insignificant reduction (Table No 4 When summerised there was significant reduction of weight in 66 patients insignificant reduction of weight in 16 patient and in 18 patients increased the weights of prostate.
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CONCLUSION
The above results may be due to the fact the active principle of drugs used in Vasti are absorbed through rectal mucosa and these act locally and systemically. Locally some changes occur in prostatic tissue leading to decreases level of the Dihydrostestosterone (DHT) the accumulation of DHT is responsible for development of benign prostate hyperplasia. After reduction of DHT at prostatic tissue leavel the prostate tends to normal. In another way the vasti is applied of Luke warm stage. So some amount of vasti drug are absorbed through rectal mucosa and it reaches the prostatic tissue.
Consequently the extra celular concentration is higher than intracellular cytoplsmic concentration according to these effects the prostatic size reduced and prostate tends to normal volume (Scheme 1) So this unique and non invasive modality of management could be considered as effective treatment of benign prostate hyperplasia.
